Waregem (Belgium), 30 October 2009 – Pursuant to the Belgian legislation of 2 May 2007 relating to the disclosure of major shareholdings in listed companies, Arseus received notification on 27 October that KBC Asset Management NV’s holding had fallen below the disclosure threshold of 3%.
Based on the denominator of 31,195,121 (total number of voting rights) and the relevant notifications, the structure of the shareholding of Arseus is as follows:
number of voting rights
% of total
Fortis Investment Management SA
2,756,357
8.84%
Omega Pharma NV*
7,500,000
24.04%
Couckinvest NV / Coucke*
3,858,080
12.37%
Arseus NV (treasury shares)
973,915
3.12%
Public
16,106,769
51.63%
* related parties as specified in the Belgian Company Code
The original notification forms are also available on the corporate website (www.arseus.com).
This is a translation of the Dutch press release; the Dutch press release prevails.
Please open the link below for the full press release: